Related references
Note: Only part of the references are listed.Animal models to explore the effects of glucocorticoids on skeletal growth and structure
Claire L. Wood et al.
JOURNAL OF ENDOCRINOLOGY (2018)
Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity
H. Herschel Conaway et al.
BONE (2016)
Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice
Imranul Alam et al.
ENDOCRINOLOGY (2016)
Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin
Amy Y. Sato et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Cortical-Bone Fragility - Insights from sFRP4 Deficiency in Pyle's Disease
Pelin O. Simsek Kiper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A joined role of canopy and reversal cells in bone remodeling - Lessons from glucocorticoid-induced osteoporosis
Pia Rosgaard Jensen et al.
BONE (2015)
Role of WNT16 in the Regulation of Periosteal Bone Formation in Female Mice
Jon E. Wergedal et al.
ENDOCRINOLOGY (2015)
The WNT system: background and its role in bone
U. H. Lerner et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture
Hou-Feng Zheng et al.
NATURE (2015)
The bone-sparing effects of estrogen and WNT16 are independent of each other
Sofia Moverare-Skrtic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures
Sofia Moverare-Skrtic et al.
NATURE MEDICINE (2014)
Acute Effects of Glucocorticoids on Serum Markers of Osteoclasts, Osteoblasts, and Osteocytes
Kristyna Brabnikova Maresova et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions
Irene E. M. Bultink et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Robert H. Oakley et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
WNT signaling in bone homeostasis and disease: from human mutations to treatments
Roland Baron et al.
NATURE MEDICINE (2013)
Glucocorticoid-Induced Osteoporosis and Osteonecrosis
Robert S. Weinstein
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2012)
Selective Glucocorticoid Receptor Modulation Maintains Bone Mineral Density in Mice
Sylvia Thiele et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives
Roland Baron et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture
Karol Estrada et al.
NATURE GENETICS (2012)
Wntless functions in mature osteoblasts to regulate bone mass
Zhendong Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Glucocorticoid receptor signaling in bone cells
Paraskevi Moutsatsou et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Meta-Analysis of Genome-Wide Scans for Total Body BMD in Children and Adults Reveals Allelic Heterogeneity and Age-Specific Effects at the WNT16 Locus
Carolina Medina-Gomez et al.
PLOS GENETICS (2012)
WNT16 Influences Bone Mineral Density, Cortical Bone Thickness, Bone Strength, and Osteoporotic Fracture Risk
Hou-Feng Zheng et al.
PLOS GENETICS (2012)
Glucocorticoids and Tumor Necrosis Factor α Increase Oxidative Stress and Suppress Wnt Protein Signaling in Osteoblasts
Maria Almeida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Glucocorticoids Suppress Bone Formation by Attenuating Osteoblast Differentiation via the Monomeric Glucocorticoid Receptor
Alexander Rauch et al.
CELL METABOLISM (2010)
Glucocorticoids Maintain Human Osteoclasts in the Active Mode of Their Resorption Cycle
Kent Soe et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Discovery of Glucocorticoid Receptor-β in Mice with a Role in Metabolism
Terry D. Hinds et al.
MOLECULAR ENDOCRINOLOGY (2010)
Management of glucocorticoid-induced osteoporosis
Juliet Compston
NATURE REVIEWS RHEUMATOLOGY (2010)
Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice
Robert Kalak et al.
BONE (2009)
Biphasic Glucocorticoid-Dependent Regulation of Wnt Expression and Its Inhibitors in Mature Osteoblastic Cells
Wendy Mak et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
The Role of Liver-Derived Insulin-Like Growth Factor-I
Claes Ohlsson et al.
ENDOCRINE REVIEWS (2009)
Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis - A longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice
Wei Yao et al.
ARTHRITIS AND RHEUMATISM (2008)
Modulation of dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss
Feng-Sheng Wang et al.
ENDOCRINOLOGY (2008)
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
E. Canalis et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Crosstalk between the glucocorticoid receptor and other transcription factors: Molecular aspects
Olivier Kassel et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis
Conor J. Hurson et al.
BMC MUSCULOSKELETAL DISORDERS (2007)
Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling
L. B. Sher et al.
CALCIFIED TISSUE INTERNATIONAL (2006)
High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: A cross-sectional outpatient study
Alberto Angeli et al.
BONE (2006)
Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-κB (NF-κB) ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvarial bones
Charlotte Swanson et al.
ENDOCRINOLOGY (2006)
Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells
E. L. Humphrey et al.
BONE (2006)
The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization
M Eijken et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts
K Ohnaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength
CA O'Brien et al.
ENDOCRINOLOGY (2004)
Transgenic expression of 11β-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone
LB Sher et al.
ENDOCRINOLOGY (2004)
Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis
K Ohnaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy
TP Van Staa et al.
ARTHRITIS AND RHEUMATISM (2003)
Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3β
E Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The epidemiology of corticosteroid-induced osteoporosis: A meta-analysis
TP van Staa et al.
OSTEOPOROSIS INTERNATIONAL (2002)
High constitutive glucocorticoid receptor β in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids
I Strickland et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Vertebral fracture risk with long-term corticosteroid therapy -: Prevalence and relation to age, bone density, and corticosteroid use
V Naganathan et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
